Champions Oncology Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Champions Oncology Inc with three other
companies in this sector in the United States:
Organovo Holdings Incorporated
sales of $4.23 million
of which 100%
was Developing and Commercializing Human Tis),
Aviragen Therapeutics Inc
Champions Oncology Inc reported sales of $15.41 million
April of 2017.
increase of 37.8%
versus 2016, when the company's sales were $11.18 million.